Sponsors & Exhibitors

Orphan Drugs & Rare Diseases 2019 West Coast

Gold Sponsor

Orphan

Eiger is a late‐stage biopharmaceutical company focused on the accelerated development and commercialization of a pipeline of targeted, first‐in‐class therapies for rare and ultra‐rare diseases. The company’s lead program is in Phase 3, developing lonafarnib, a first‐in‐class prenylation inhibitor for the treatment of Hepatitis Delta Virus (HDV) infection. The company is also preparing an NDA with plans to file in 2019 for lonafarnib in the treatment of Hutchinson‐Gilford Progeria Syndrome (HGPS or Progeria) and Progeroid Laminopathies. For additional information about Eiger, please visit www.eigerbio.com.

Visit Website

Gold Sponsor

Orphan

Invitae Corporation (NYSE: NVTA) is a genetics company whose mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Invitae’s goal is to aggregate most of the world’s genetic tests into a single service with higher quality, faster turnaround time and lower prices.

Visit Website

Gold Sponsor

Orphan

Durbin is one of the leading providers of comparator sourcing and managed access
programs to pharmaceutical and biotech companies around the world. In its 55th
year of business, Durbin is pleased to look back on a history of sourcing
pharmaceuticals for physicians and patients around the world and even in 3rd world
countries, providing urgent and cost effective supply of pharmaceuticals to global
charity and relief organizations and of course its pharmaceutical services division
who source and distribute comparator drugs for clinical trials and run managed
access programs that provide access to needed pharmaceuticals in non-approved
markets. Durbin’s distribution network includes regular shipments to over 180
countries globally. Their managed access programs include orphan, gene, and
controlled products. Durbin has full service offices in the United Kingdom, European
Union and United States.

Visit Website

Silver Sponsor

Orphan

Pulse Infoframe Inc (Pulse) believes that collaboration cures disease and Pulse enables such collaboration. A new style of healthcare informatics company, Pulse builds and supports global, healthcare ecosystems. It’s solution, healthie™, empowers consortia of pharmaceutical and medical device companies, researchers, clinicians, advocacy groups and patients, by aggregating information from a variety of sources and then, delivering key healthcare insights – real time -- derived from these data. For patients with rare diseases, Pulse’s global coverage is critical. Already great strides have been made in characterizing rare diseases using Pulse’s global and national registries. These insights help professionals to advance medical research, focus clinical trial recruitment, assist advocacy groups in their dealings with policy makers and provide real-world evidence.

Visit Website

Bronze Sponsor

Orphan

rareLife solutions is the rareForward scientific agency built on the insight that rare patients, advocates, and caregivers (PACs) are the primary shapers of their rare disease ecosystem.
But we do more than talk about them - we action them, regularly engage them, and integrate them in everything that we do to create a truly collaborative, responsive multi-stakeholder, patient-–driven rare community. We have developed thinking, services, tools, and solutions, including our flagship onevoice.world community platform, that can help you rareForward too.

Visit Website

To Sponsor/Exhibit

To Speak

To Register

sponsor@paradigmglobalevents.com
Tel. +44 203 567 1321

jocelynr@paradigmglobalevents.com
Tel. +44 203 567 1321

booking@paradigmglobalevents.com
Tel. +44 203 567 1321